From Biologics to Biosimilars—How Will the Market Evolve?
In this article, Decision Resources guides you through the Biologics/ Biosimilars conundrum with the aid of data from Productview Plus and the Pharmaview Research Suite.
Click here to download paper.
Invaluable Corporate and Commercial Analysis of the Biopharmaceutical Industry
Pharmaview offers all the insight you need to understand how each player in the biopharmaceutical industry functions.
Financial information, individual company breakdown, therapeutic analysis and impact of major events are all contained in a subscription to Pharmaview. With its wealth of industry experience and independent objective insight, Decision Resources’ Pharmaview offers you the information you need to make the right decisions for your business.
Features
Regular Updating—Our analysis is updated and reviewed regularly. Decision Resources’ analysts cover a range of therapy area conferences, company R&D days, annual general meetings and quarterly earnings conference calls, providing analysis and insight updated directly into the relevant online documents.
Custom Reports—Our custom reports feature enables users to select key information for inclusion into a custom-built .pdf document for printing or downloading. In addition, saved custom reports will be automatically updated with the latest analysis each time our analysts modify a company, therapy area or forecast document.
Search—Our user search function allows users to search for keywords across the entire research suite, providing results ranked by relevance.